Neurophysiologic and ophthalmic markers of chemotherapy-related cognitive impairment in patients diagnosed with hematologic cancer: A feasibility study-Reference-Cited by-同舟云学术

Neurophysiologic and ophthalmic markers of chemotherapy-related cognitive impairment in patients diagnosed with hematologic cancer: A feasibility study

Published:2020-03 Issue: Volume:410 Page:116644
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Anderson David E.^ORCID,Kedar Sachin^ORCID,Bhatt Vijaya R.,Schmid Kendra,Holstein Sarah A.,Rizzo Matthew

Funder

Fred & Pamela Buffett Cancer Center

National Cancer Institute

National Institute on Aging

National Institute of General Medical Sciences

Research Support Funds

Clinical Research Center

University of Nebraska Medical Center

Department of Neurological Sciences

Fremont Area Alzheimer Committee Grant

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference49 articles.

1. Prevalence, mechanisms, and management of cancer-related cognitive impairment;Janelsins;Int. Rev. Psychiatry,2014

2. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science;Ahles;J. Clin. Oncol.,2012

3. New challenges in psycho-oncology research IV: cognition and cancer: conceptual and methodological issues and future directions;Ahles;Psychooncology.,2018

4. Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: a systematic review;Li;Neurosci. Biobehav. Rev.,2018

5. Chemobrain: a systematic review of structural and functional neuroimaging studies;Simó;Neurosci. Biobehav. Rev.,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a National Study That Integrates the Geriatric Assessment into the Care of Older Patients with Myeloid Malignancies;Current Oncology Reports;2024-09-11

2. Cancer-related cognitive impairment in racial and ethnic minority groups: a scoping review;Journal of Cancer Research and Clinical Oncology;2023-07-11

3. Neurocognitive function and quality-of-life in patients with colorectal cancer;European Journal of Oncology Nursing;2023-06

4. Lower tumor burden is associated with better cognitive function in patients with chronic phase chronic myeloid leukemia;Leukemia & Lymphoma;2022-05-11

5. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events;Archives of Toxicology;2021-11-02